Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous vs. Intramuscular Testosterone for Gender Affirming Therapy
NCT02229617Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Jul 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone in gender dysphoria (GD), sponsored by University of British Columbia. Started Jul 2015; status: completed.
02
Drugs
testosterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT02229617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229617.